-Oxoprenolol%20Structural%20Formulae%20V.2.svg)
oxprenolol
Sign in to saveOxprenolol, sold under the brand name Trasicor among others, is a non-selective beta blocker with some intrinsic sympathomimetic activity. It is used for the treatment of angina pectoris, abnormal heart rhythms, and high blood pressure.
Research
1,351 papers- Oxprenolol in clinical practice.The American journal of cardiology · 1983
- Oxprenolol: clinical pharmacology, pharmacokinetics, and pharmacodynamics.The American journal of cardiology · 1983
- Fatal oxprenolol poisoning.British medical journal · 1977
- Oxprenolol hydrochloride: pharmacology, pharmacokinetics, adverse effects and clinical efficacy.Pharmacotherapy · 1983
- The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model.Journal of cachexia, sarcopenia and muscle · 2023
via PubMed
Article
10 sectionsContents
- Medical uses
- Contraindications
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Chemistry
- Stereochemistry
- Society and culture
- Brand names
- References
Oxprenolol, sold under the brand name Trasicor among others, is a non-selective beta blocker with some intrinsic sympathomimetic activity. It is used for the treatment of angina pectoris, abnormal heart rhythms, and high blood pressure.
==Medical uses== Oxprenolol is used in the treatment of angina pectoris, abnormal heart rhythms, and high blood pressure.